Publications by authors named "G Kvalheim"

Claim this Profile
P
Production of mRNA-Loaded Dendritic Cell Cancer Vaccines.
Turid Kirsti Hønnåshagen, Lisbeth Johanne Skoge, Stein Sæbøe-Larssen, Hege Håkenstad, Gunnar Kvalheim

Methods Mol Biol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.
Solrun Melkorka Maggadottir, Svein Dueland, Nadia Mensali, Hanne Hamre, Per Arne Andresen, Gunnar Kvalheim

Mol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia.
Benjamin Caulier, Sandy Joaquina, Pascal Gelebart, Tara Helén Dowling, Fatemeh Kaveh, Gunnar Kvalheim

Cell Rep Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16.
Nicholas P Casey, Katrin Kleinmanns, Christopher Forcados, Pascal F Gelebart, Sandy Joaquina, Gunnar Kvalheim

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy.
Yngvar Fløisand, Mats Remberger, Iris Bigalke, Dag Josefsen, Helen Vålerhaugen, Gunnar Kvalheim

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis